 | • レポートコード：B-GIR08C4756 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、人間用予防ワクチンの世界市場について調べ、まとめました。種類別セグメントは、不活化ワクチン、弱毒化ワクチン、その他等、用途別セグメントは、病院、科学研究、その他等に区分しました。人間用予防ワクチンの世界市場概観、企業動向、企業別人間用予防ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・人間用予防ワクチンの市場概観 ・人間用予防ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・人間用予防ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・人間用予防ワクチンの世界市場規模 ・人間用予防ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・人間用予防ワクチンのアメリカ市場規模推移 ・人間用予防ワクチンのカナダ市場規模推移 ・人間用予防ワクチンのメキシコ市場規模推移 ・人間用予防ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・人間用予防ワクチンのドイツ市場規模推移 ・人間用予防ワクチンのイギリス市場規模推移 ・人間用予防ワクチンのロシア市場規模推移 ・人間用予防ワクチンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・人間用予防ワクチンの日本市場規模推移 ・人間用予防ワクチンの中国市場規模推移 ・人間用予防ワクチンの韓国市場規模推移 ・人間用予防ワクチンのインド市場規模推移 ・人間用予防ワクチンの東南アジア市場規模推移 ・人間用予防ワクチンの南米市場分析（ブラジル、アルゼンチン等） ・人間用予防ワクチンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・人間用予防ワクチンの種類別分析/販売量、売上、市場シェア（不活化ワクチン、弱毒化ワクチン、その他） ・人間用予防ワクチンの用途別分析/市場規模（病院、科学研究、その他） ・人間用予防ワクチンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・人間用予防ワクチンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Prophylactic Human Vaccine is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Prophylactic Human Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GSK
Biovac
McKesson Medical
Merck
Merial
Zoetis
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Inactivated Vaccine
Attenuated Vaccine
Others
Market Segment by Applications, can be divided into
Hospital
Scientific Research
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prophylactic Human Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prophylactic Human Vaccine, with price, sales, revenue and global market share of Prophylactic Human Vaccine in 2017 and 2018.
Chapter 3, the Prophylactic Human Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prophylactic Human Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Prophylactic Human Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Prophylactic Human Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Prophylactic Human Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Inactivated Vaccine
1.2.2 Attenuated Vaccine
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Scientific Research
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Prophylactic Human Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Biovac
2.2.1 Business Overview
2.2.2 Prophylactic Human Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Biovac Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 McKesson Medical
2.3.1 Business Overview
2.3.2 Prophylactic Human Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 McKesson Medical Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merck
2.4.1 Business Overview
2.4.2 Prophylactic Human Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merial
2.5.1 Business Overview
2.5.2 Prophylactic Human Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merial Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Zoetis
2.6.1 Business Overview
2.6.2 Prophylactic Human Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Zoetis Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Prophylactic Human Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Prophylactic Human Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Prophylactic Human Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Prophylactic Human Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Prophylactic Human Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Prophylactic Human Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Prophylactic Human Vaccine Market Analysis by Regions
4.1 Global Prophylactic Human Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Prophylactic Human Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Prophylactic Human Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
5 North America Prophylactic Human Vaccine by Country
5.1 North America Prophylactic Human Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Prophylactic Human Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Prophylactic Human Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
6 Europe Prophylactic Human Vaccine by Country
6.1 Europe Prophylactic Human Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Prophylactic Human Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Prophylactic Human Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
6.4 France Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Prophylactic Human Vaccine by Country
7.1 Asia-Pacific Prophylactic Human Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Prophylactic Human Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Prophylactic Human Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
7.5 India Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
8 South America Prophylactic Human Vaccine by Country
8.1 South America Prophylactic Human Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Prophylactic Human Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Prophylactic Human Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Prophylactic Human Vaccine by Countries
9.1 Middle East and Africa Prophylactic Human Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Prophylactic Human Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Prophylactic Human Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
10 Global Prophylactic Human Vaccine Market Segment by Type
10.1 Global Prophylactic Human Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Prophylactic Human Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global Prophylactic Human Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Inactivated Vaccine Sales Growth and Price
10.2.1 Global Inactivated Vaccine Sales Growth (2014-2019)
10.2.2 Global Inactivated Vaccine Price (2014-2019)
10.3 Attenuated Vaccine Sales Growth and Price
10.3.1 Global Attenuated Vaccine Sales Growth (2014-2019)
10.3.2 Global Attenuated Vaccine Price (2014-2019)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2014-2019)
10.4.2 Global Others Price (2014-2019)
11 Global Prophylactic Human Vaccine Market Segment by Application
11.1 Global Prophylactic Human Vaccine Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Scientific Research Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 Prophylactic Human Vaccine Market Forecast (2019-2024)
12.1 Global Prophylactic Human Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Prophylactic Human Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America Prophylactic Human Vaccine Market Forecast (2019-2024)
12.2.2 Europe Prophylactic Human Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Prophylactic Human Vaccine Market Forecast (2019-2024)
12.2.4 South America Prophylactic Human Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Prophylactic Human Vaccine Market Forecast (2019-2024)
12.3 Prophylactic Human Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global Prophylactic Human Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global Prophylactic Human Vaccine Market Share Forecast by Type (2019-2024)
12.4 Prophylactic Human Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global Prophylactic Human Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global Prophylactic Human Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Prophylactic Human Vaccine Picture
Table Product Specifications of Prophylactic Human Vaccine
Figure Global Sales Market Share of Prophylactic Human Vaccine by Types in 2018
Table Prophylactic Human Vaccine Types for Major Manufacturers
Figure Inactivated Vaccine Picture
Figure Attenuated Vaccine Picture
Figure Others Picture
Figure Prophylactic Human Vaccine Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Scientific Research Picture
Figure Others Picture
Figure United States Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure France Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure UK Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure China Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure India Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Prophylactic Human Vaccine Revenue (Value) and Growth Rate (2014-2024)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Prophylactic Human Vaccine Type and Applications
Table GSK Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biovac Basic Information, Manufacturing Base and Competitors
Table Biovac Prophylactic Human Vaccine Type and Applications
Table Biovac Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table McKesson Medical Basic Information, Manufacturing Base and Competitors
Table McKesson Medical Prophylactic Human Vaccine Type and Applications
Table McKesson Medical Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Prophylactic Human Vaccine Type and Applications
Table Merck Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merial Basic Information, Manufacturing Base and Competitors
Table Merial Prophylactic Human Vaccine Type and Applications
Table Merial Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Zoetis Basic Information, Manufacturing Base and Competitors
Table Zoetis Prophylactic Human Vaccine Type and Applications
Table Zoetis Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Prophylactic Human Vaccine Type and Applications
Table Sanofi Prophylactic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Prophylactic Human Vaccine Sales by Manufacturer (2017-2018)
Figure Global Prophylactic Human Vaccine Sales Market Share by Manufacturer in 2017
Figure Global Prophylactic Human Vaccine Sales Market Share by Manufacturer in 2018
Table Global Prophylactic Human Vaccine Revenue by Manufacturer (2017-2018)
Figure Global Prophylactic Human Vaccine Revenue Market Share by Manufacturer in 2017
Figure Global Prophylactic Human Vaccine Revenue Market Share by Manufacturer in 2018
Figure Top 3 Prophylactic Human Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Prophylactic Human Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Global Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Global Prophylactic Human Vaccine Revenue and Growth Rate (2014-2019)
Table Global Prophylactic Human Vaccine Sales by Regions (2014-2019)
Table Global Prophylactic Human Vaccine Sales Market Share by Regions (2014-2019)
Table Global Prophylactic Human Vaccine Revenue by Regions (2014-2019)
Figure Global Prophylactic Human Vaccine Revenue Market Share by Regions in 2014
Figure Global Prophylactic Human Vaccine Revenue Market Share by Regions in 2018
Figure North America Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Europe Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure South America Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure North America Prophylactic Human Vaccine Revenue and Growth Rate (2014-2019)
Table North America Prophylactic Human Vaccine Sales by Countries (2014-2019)
Table North America Prophylactic Human Vaccine Sales Market Share by Countries (2014-2019)
Figure North America Prophylactic Human Vaccine Sales Market Share by Countries in 2014
Figure North America Prophylactic Human Vaccine Sales Market Share by Countries in 2018
Table North America Prophylactic Human Vaccine Revenue by Countries (2014-2019)
Table North America Prophylactic Human Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America Prophylactic Human Vaccine Revenue Market Share by Countries in 2014
Figure North America Prophylactic Human Vaccine Revenue Market Share by Countries in 2018
Figure United States Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Canada Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Mexico Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Europe Prophylactic Human Vaccine Revenue and Growth Rate (2014-2019)
Table Europe Prophylactic Human Vaccine Sales by Countries (2014-2019)
Table Europe Prophylactic Human Vaccine Sales Market Share by Countries (2014-2019)
Table Europe Prophylactic Human Vaccine Revenue by Countries (2014-2019)
Figure Europe Prophylactic Human Vaccine Revenue Market Share by Countries in 2017
Figure Europe Prophylactic Human Vaccine Revenue Market Share by Countries in 2018
Figure Germany Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure UK Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure France Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Russia Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Italy Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Prophylactic Human Vaccine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Prophylactic Human Vaccine Sales by Countries (2014-2019)
Table Asia-Pacific Prophylactic Human Vaccine Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Prophylactic Human Vaccine Sales Market Share by Countries 2018
Table Asia-Pacific Prophylactic Human Vaccine Revenue by Countries (2014-2019)
Figure Asia-Pacific Prophylactic Human Vaccine Revenue Market Share by Countries 2018
Figure China Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Japan Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Korea Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure India Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Southeast Asia Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure South America Prophylactic Human Vaccine Revenue and Growth Rate (2014-2019)
Table South America Prophylactic Human Vaccine Sales by Countries (2014-2019)
Table South America Prophylactic Human Vaccine Sales Market Share by Countries (2014-2019)
Figure South America Prophylactic Human Vaccine Sales Market Share by Countries in 2018
Table South America Prophylactic Human Vaccine Revenue by Countries (2014-2019)
Table South America Prophylactic Human Vaccine Revenue Market Share by Countries (2014-2019)
Figure South America Prophylactic Human Vaccine Revenue Market Share by Countries in 2018
Figure Brazil Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Argentina Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Colombia Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Prophylactic Human Vaccine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Prophylactic Human Vaccine Sales by Countries (2014-2019)
Table Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Prophylactic Human Vaccine Sales Market Share by Countries in 2018
Table Middle East and Africa Prophylactic Human Vaccine Revenue by Countries (2014-2019)
Table Middle East and Africa Prophylactic Human Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Prophylactic Human Vaccine Revenue Market Share by Countries in 2014
Figure Middle East and Africa Prophylactic Human Vaccine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure UAE Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Egypt Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure Nigeria Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Figure South Africa Prophylactic Human Vaccine Sales and Growth Rate (2014-2019)
Table Global Prophylactic Human Vaccine Sales by Type (2014-2019)
Table Global Prophylactic Human Vaccine Sales Share by Type (2014-2019)
Table Global Prophylactic Human Vaccine Revenue by Type (2014-2019)
Table Global Prophylactic Human Vaccine Revenue Share by Type (2014-2019)
Figure Global Inactivated Vaccine Sales Growth (2014-2019)
Figure Global Inactivated Vaccine Price (2014-2019)
Figure Global Attenuated Vaccine Sales Growth (2014-2019)
Figure Global Attenuated Vaccine Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Prophylactic Human Vaccine Sales by Application (2014-2019)
Table Global Prophylactic Human Vaccine Sales Share by Application (2014-2019)
Figure Global Scientific Research Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Prophylactic Human Vaccine Sales, Revenue and Growth Rate (2019-2024)
Table Global Prophylactic Human Vaccine Sales Forecast by Regions (2019-2024)
Table Global Prophylactic Human Vaccine Market Share Forecast by Regions (2019-2024)
Figure North America Sales Prophylactic Human Vaccine Market Forecast (2019-2024)
Figure Europe Sales Prophylactic Human Vaccine Market Forecast (2019-2024)
Figure Asia-Pacific Sales Prophylactic Human Vaccine Market Forecast (2019-2024)
Figure South America Sales Prophylactic Human Vaccine Market Forecast (2019-2024)
Figure Middle East and Africa Sales Prophylactic Human Vaccine Market Forecast (2019-2024)
Table Global Prophylactic Human Vaccine Sales Forecast by Type (2019-2024)
Table Global Prophylactic Human Vaccine Market Share Forecast by Type (2019-2024)
Table Global Prophylactic Human Vaccine Sales Forecast by Application (2019-2024)
Table Global Prophylactic Human Vaccine Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
はしかワクチンの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Measle Vaccine is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Measle Vaccine in global market, e…- ヒトロタウイルスワクチンの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Human Rotavirus Vaccine is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Human Rotavirus Vaccine i…
- ワクチン保管機器の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Vaccine Storage Equipment is a refrigerated equipment used for the transportation and Storage of vaccines. Scope of the Report: The worldwide market for Vaccine Storage Equipment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million…
- ワクチンコンジュゲートの世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Vaccine Conjugate is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Vaccine Conjugate in global mar…
- ワクチン等温輸送ボックスの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Vaccine Isothermal Transport Box is an innovative insulated packaging used for the transportation of Vaccine at controlled temperatures. It efficiently preserves the products from thermal and physical shocks, and most pathogens cannot survive at sub-zero temperatures. Scope of the Report: The worldw…